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ABSTRACT 
Maternal high fat (HF) diet feeding is associated with increased risk of 
developing metabolism-related diseases in adult offspring, including chronic liver 
disease. The present study tested the hypothesis that maternal high fat diet leads 
to a decreased antioxidant defense capacity and causes cellular senescence in 
liver of adult offspring rats, which might increase risk of developing chronic liver 
disease.  Timed-pregnant Sprague Dawley rats were fed a HF diet (45% of energy 
from fat) or a control (C) diet (16% of energy from fat) during gestation and 
lactation. The resulting offspring were fed a control diet after weaning, to generate 
two offspring groups: C/C and HF/C.  At 12 wk of age, male rats were killed and 
samples were collected for analysis.  Maternal HF diet significantly increased 
plasma triacylglycerol and hepatic thiobarbituric acid reactive substance 
concentrations and the size of hepatic lipid droplets in offspring rats. The 
expression of antioxidant defense genes, such as glutathione peroxidase-1 (Gpx1), 
Cu/Zn superoxide dismutase (Sod1), paraoxonase enzymes (Pon1, Pon2, and 
Pon3) were significantly lower in the liver of HF/C pups than in C/C pups. The 
expression of p16INK4a, a marker of cellular senescence, and cyclooxygenase-2 
(Cox2), a pro-inflammatory marker, was significantly higher in the HF/C offspring 
group than in the C/C offspring group.  Western blot analysis shows that cyclin D1 
and phosphorylated retinoblastoma (p-Rb) protein were significantly lower in HF/C 
offspring than in C/C offspring.  The results provide the first evidence that maternal 
HF diet might alter antioxidant defense capacity and program the p16INK4a-
dependent cellular senescence in the liver of adult offspring. 
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CHAPTER 1 
INTRODUCTION 
Appropriate maternal nutrition during gestation and lactation plays important 
role for offspring to perform normal metabolic function, while maternal malnutrition 
may lead to metabolism related disorders in offspring including obesity, type 2 
diabetes, hypertension and hyperlipidemia (Barker et al., 1993). Mitogen-
dependent mammalian cell progression is regulated by complexes formed with 
cyclin dependent kinases (CDKs) and cyclin, which are under tight control of 
inhibitors of cyclin dependent kinases (CDIs). The expression and activity of CDIs 
can be affected by inappropriate maternal diet, which will make the offspring more 
propensity to several diseases in their later life (Tarry-Adkins et al., 2009).  
Because of the importance of maternal nutrition on the development of 
offspring and on the control of cell cycle pathways, knowledge of fetal 
development of metabolic diseases and cell cycle control are needed for further 
research. The potential mechanism of how the cell cycle pathways are 
programmed by maternal nutrition can be understood. 
Literature Cited 
Barker, D.J., Hales, C.N., Fall, C.H., Osmond, C., Phipps, K., and Clark, P.M. 
(1993). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and 
hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36, 
62-67. 
 
Tarry-Adkins, J.L., Chen, J.H., Smith, N.S., Jones, R.H., Cherif, H., and Ozanne, 
S.E. (2009). Poor maternal nutrition followed by accelerated postnatal growth 
leads to telomere shortening and increased markers of cell senescence in rat 
islets. FASEB J 23, 1521-1528. 
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CHAPTER 2 
LITERATURE REVIEW 
Maternal Nutrition and Developmental Origins of Diseases 
Maternal nutrition during gestation is important for fetus development with 
regard of the nutrient provided through placenta, while the effect of maternal diet 
on breast milk plays significant role in postnatal offspring during lactation. Maternal 
malnutrition is the origin of many metabolic disorders happens to offspring in their 
later life. Hales and Barker proposed a “thrifty phenotype hypothesis” in 1992, 
demonstrating the association of malnutrition in fetal and early infant life to the 
damage of β-cells and the risk of type 2 diabetes in later life (Hales and Barker, 
1992). Later, they established the relation of type 2 diabetes, hypertension, and 
hyperlipidemia to reduced birth weight induced by maternal undernutrition (Barker 
et al., 1993). Function of different internal organs in offspring can be affected by 
maternal malnutrition. 
Maternal nutrition has tremendous effect on the function of pancreatic β-
cells in offspring, demonstrating the association of maternal malnutrition to the 
development of type 2 diabetes in offspring’s later life. Hales et al. studied 468 
men born in east Hertfordshire and reported the association between low birth 
weight (LBW) induced by maternal malnutrition and the impaired glucose tolerance 
(Hales et al., 1991). Their study demonstrated that the impaired glucose tolerance 
caused by dysfunction of pancreatic β-cells is strongly linked with the reduced 
early growth. One study of maternal feed restriction on guinea pigs also showed 
reduced fetal growth, hyperinsulinemia and insulin resistance in male offspring 
(Kind et al., 2003). Following studies tried to explain the mechanism of 
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programmed increased risk of type 2 diabetes caused by maternal protein 
restriction (Tarry-Adkins et al., 2010; Tarry-Adkins et al., 2009). They first 
proposed that poor maternal nutrition followed by catch-up growth is associated 
with increased cellular senescence and decrease antioxidant defense capacity in 
rat islets. Followed up, they reported increased oxidative stress and fibrosis in 15 
month rats offspring from dams fed a LP diet, indicating that maternal malnutrition 
can lead to type 2 diabetes in offspring’s later life.  
Maternal malnutrition can lead to the damage of kidney and the related 
metabolic diseases. When Hales and Barker proposed the “thrifty phenotype 
hypothesis”, they reported higher risk of hypertension in offspring experienced 
imbalanced early nutrition without digging into the mechanism related to the 
dysfunction of kidney. Accelerated senescence and reactive oxygen species have 
been reported in the kidneys of LBW rats after catch-up growth, suggesting the 
link between poor early growth induced by maternal malnutrition and the risk of 
hypertension in later life (Luyckx et al., 2009). Another study reported that 
maternal LP diet can program significant reduction in nephron number, glomerular 
volume and renal AT1 and AT2 receptor protein expression, indicating the 
association between elevated blood pressure and morphological change in 
kidneys of offspring rats induced by maternal protein restriction (Alwasel et al., 
2010). It was also reported that offspring from dams fed a LP diet are more 
sensitive to stress and high-salt diet and may predispose for hypertension in later 
life (Augustyniak et al., 2010). Furthermore, the hypertension programmed by 
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maternal malnutrition can highly increase the risk of cardiovascular disease in 
adult offspring.  
Offspring who experienced malnutrition in early life are likely to have higher 
blood pressure and higher risk of cardiovascular disease in their later life. It was 
reported that moderate balanced undernutrition in guinea pigs can increase 
systolic blood pressure in young adult male offspring (Kind et al., 2002). Maternal 
obesity was reported to induce greater fetal heart connective tissue accumulation, 
indicating a negative impact of maternal malnutrition in offspring’s heart function 
(Huang et al., 2010). Increased mortality rate induce by maternal malnutrition has 
been associated to the increased risk of coronary heart disease in those offspring. 
The association between LBW and increased risk of coronary heart disease has 
been repeatedly confirmed (Barker, 1997). It was reported that a HF diet during 
pregnancy can lead to vascular dysfunction in rat weanlings (Koukkou et al., 1998).  
Liver, as an important organ in regulating metabolism, can be significantly 
affected by maternal malnutrition and is greatly associated with chronic disease in 
later life. It was reported that protein restriction and folic acid supplement during 
pregnancy can change hepatic gene expression in rat offspring and the difference 
of DNA methylation on those genes may explain the mechanism (Lillycrop et al., 
2005; Lillycrop et al., 2010). Maternal LP diet during gestation and lactation can 
decrease hepatic lipid content in male offspring, indicating the change of lipid 
metabolism can be programmed by maternal malnutrition (Qasem et al., 2010; 
Torres et al., 2010). Programmed hepatic antioxidant capacity and oxidative injury 
was reported in aging rat offspring from dams fed a LP diet (Langley-Evans and 
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Sculley, 2005). Hepatic lipid metabolism and gene expression can also be 
programmed by maternal HF diet during pregnancy and lactation (Bruce et al., 
2009; Ghebremeskel et al., 1999; McCurdy et al., 2009; Zhang et al., 2009). 
Chronic liver diseases, like non-alcoholic fatty liver disease, can be induced in 
adult offspring from dams of malnutrition during pregnancy (Bruce et al., 2009; 
Elahi et al., 2009).  
Other organs can be affected by maternal malnutrition, like mammary gland, 
skeleton muscle and adipose tissues. Maternal protein restriction can cause 
transcriptional repression of p16INK4a in mammary gland through histone 
modification (Zheng and Pan, 2010). The expression of CCAAT/enhancer-binding 
protein was programmed through histone modification on the gene in the skeleton 
muscle of offspring from dams fed a LP diet (Zheng et al., 2011).  
To sum up, maternal nutrition during pregnancy and lactation plays pivotal 
role in providing a healthy early environment for offspring in order to minimize the 
risk of metabolism disorder in later life. The association between maternal 
malnutrition and metabolic disease in later life has been established. Maternal HF 
diet and obesity have been related to hypertension, hyperlipidemia, impaired 
insulin tolerance, fatty liver disease and other chronic disorders in offspring’s later 
life (Bruce and Hanson, 2010). In this study, I investigated the potential impact of 
maternal HF diet on the livers of male offspring. 
Maternal High-Fat Exposure and Dyslipidemia 
Maternal HF exposure during pregnancy can trigger several metabolic 
disorders in offspring, including cardiovascular disease, hypertension, dyslipidemia 
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and chronic liver diseases. It was reported that offspring from dams fed a diet high 
in saturated fat for 10 days before mating, through gestation and lactation have 
damaged function of vascular system (Koukkou et al., 1998). Plasma triglyceride 
content has been reported to be increased in those offspring from HF diet fed 
dams (Chapman et al., 2000; Elahi et al., 2009; Guo and Jen, 1995; Koukkou et al., 
1998; Odaka et al., 2010) 
Dyslipidemia is defined as abnormal lipid content in blood, hyperlipidemia in 
most cases. Maternal HF exposure during gestation and lactation can program 
dyslipidemia in the young or adult offspring, including hypercholesterol and 
hypertriglyceride in the blood. Offspring rats from dams fed a HF diet had higher 
plasma triglyceride compared to those from C diet fed dams (Chapman et al., 
2000; Guo and Jen, 1995). Blood cholesterol was also significantly higher in 
offspring rats from long-term HF diet fed dams (Elahi et al., 2009). 
Hypertriglyceride can be programmed by maternal HF diet during gestation and 
lactcation and can cause damage to cardiovascular system and problem of 
hepatic lipid metabolism 
Liver, as a critical organ for lipid metabolism, can be greatly affected by 
maternal HF exposure. mRNA level of genes related to hepatic lipid metabolism, 
including peroxisome proliferator activated receptor-alpha (ppar-alpha) and 
carnitine palmitoyl transferase-1a (cpt-1a) can be changed by maternal HF diet 
(Shankar et al., 2010; Zhang et al., 2009). The concentration of docosahexaenoic 
acid (DHA) was significantly lower in livers of offspring from dam rats fed a HF diet 
for 10 days before mating, through gestation and lactation, indicating that maternal 
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HF exposure can lose the cardio-protective and anti-inflammatory function of the 
body (Ghebremeskel et al., 1999). The expression of hepatic genes can be 
changed in offspring by chronic maternal HF exposure through epigenetic 
modification, including the alteration of histone modification and DNA methylation 
(Aagaard-Tillery et al., 2008). It was also reported that maternal HF diet can trigger 
lipotoxicity in fetal livers (McCurdy et al., 2009). Several models of maternal HF 
exposure have reported that maternal HF diet can program chronic liver disease 
including non-alcoholic fatty liver disease and steatosis in offspring (Bruce et al., 
2009; Elahi et al., 2009). Those metabolic disorders in livers of offspring, which 
were programmed by maternal overnutrition, are highly associated with the 
dyslipidemia in those offspring. 
Some other function of the offspring can be affected by chronic maternal HF 
exposure. It has been reported that immune function of offspring was altered by 
maternal HF diet during gestation and lactation (Odaka et al., 2010). Mild maternal 
overnutrition can cause the increased adiposity and altered the brain appetite 
regulator in offspring (Rajia et al., 2010).  
To sum up, maternal HF exposure has vital impact on the metabolic 
function in offspring, including the increased blood lipid content, increased hepatic 
triglyceride concentration, propensity to chronic liver diseases and dysfunction of 
other organs. 
Hepatic Lipid Metabolism and Non-Alcoholic Fatty Liver Disease 
Non-alcoholic fatty liver disease (NAFLD), which is defined as the abnormal 
accumulation of lipid, primarily in the form of triacylglycerols (TAG) in the livers of 
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individuals who do not consume significant amounts of alcohol (20 g ethanol per 
day) and in whom other known causes of steatosis, such as certain drugs and 
toxins, have been excluded (McCullough, 2004), is the most common chronic liver 
disease. NAFLD prevalence is 10-24% in normal population, and it increases to 
25-75% in obese population (Angulo, 2002). Two “hits” theory has been proposed 
for the pathophysiology of NAFLD while the exact cause still remains unclear. The 
first “hit” is insulin resistance, which leads to steatosis. The second “hit” is 
oxidative stress, which leads to the production of lipid peroxidation and the 
activation of inflammatory cytokines (Youssef and McCullough, 2002). There are 
many potential possibilities behind the reason of NAFLD (Angulo, 2002; Day and 
James, 1998), including medications, metabolic and genetic factors, nutritional 
status, and other uncommon factors. 
Different animal models have been identified to study the pathophysiology 
of NAFLD. Firstly, effect of different dietary factors in modulating liver steatosis 
has been repeatedly reported: saturated fat, monounsaturated fatty acids, 
polyunsaturated fatty acids, trans fatty acids, n-3 fatty acids, glycemic index and 
fiber, sucrose and fructose, and protein (Zivkovic et al., 2007). Several animal 
models have been reported to establish the association between diet and the 
genesis of NAFLD: methionine-choline deficiency (MCD) diet, HF diet and sucrose 
diet with or without high caloric intake (Basaranoglu et al., 2010). A diet high in fat 
can increase hepatic lipid content and plasma insulin concentration, causing 
insulin resistance and increased risk of NAFLD in obese populations (Vilar et al., 
2008). Being consistent with a typical American cafeteria diet, a HF diet containing 
	   9 
45% kcal from fat can trigger NAFLD in murine (Aagaard-Tillery et al., 2008; Bruce 
et al., 2009). Interestingly, n-3 polyunsaturated fatty acids have been reported to 
ameliorate the degree of liver injury in a high-fat, high-caloric diet induced NAFLD 
model (Svegliati-Baroni et al., 2006). A novel rats model found that the chemical 
hypoxemia can enhance the HF diet induced NAFLD (Takayama et al., 2009). The 
widely used MCD diet can develop liver inflammation as early as three days after 
feeding by eliminating two essential components for very-low-density-lipoprotein 
(VLDL) production and hepatic β-oxidation (Fan and Qiao, 2009). By using the 
MCD diet, animal models with severe liver damage can be developed (Larter and 
Yeh, 2008; Schattenberg and Galle, 2010). Another commonly used diet, 
atherogenic diet (cholic acid and high cholesterol), has been reported to trigger 
NAFLD (Larter and Yeh, 2008; Schattenberg and Galle, 2010). Furthermore, 
female rats fed a diet high in unsaturated fat, not a HF diet, have been reported to 
be a powerful model to study the pathogenesis of NAFLD (Tipoe et al., 2009). 
Secondly, genetically modified animal models have been developed to study the 
pathogenesis of NAFLD, including ob/ob mice (lacking leptin), db/db and fa/fa 
mice (lacking leptin receptor), KK-Ay/a mice, SREBP-1c mice, and other murine 
models (Schattenberg and Galle, 2010). Third, the animal models using 
combination of genetic modification and dietary challenge have been reported to 
induce NAFLD (Fan and Qiao, 2009). Lastly, maternal high-fat diet during 
gestation and lactation has been reported to program NAFLD in the offspring 
(Bruce et al., 2009; Oben et al., 2010). 
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Although the exact mechanism behind the pathophysiology of NAFLD 
remains elusive, studying the hepatic lipid metabolism can partially help to explain 
the abnormal accumulation of triglyceride in the liver. The imbalance among four 
major pathways of lipid metabolism contributes to the development of NAFLD, 
including the de novo lipogenesis, the fatty acid oxidation, the formation and 
secretion of VLDL, and the hepatic uptake of fatty acids (Angulo, 2002; Fabbrini et 
al., 2010; Tessari et al., 2009). The rate of de novo lipogenesis is regulated by the 
FA synthase complex, acetyl-CoA carboxylase (ACC), diacylglycerol 
acyltransferase (DGAT), stearoyl-CoA desaturase 1, and several nuclear 
transcription factors. De novo lipogenesis can be regulated independently by 
insulin and glucose through the nuclear transcription factors (Fabbrini et al., 2010). 
Fatty acid oxidation happens in mitochondria (majority), peroxisomes and 
microsomes (much less). Carnitine palmitoyltransferase-1 (CPT-1) is the rate-
limiting and key component of regulation of the mitochondrial fatty acid β-oxidation 
(Tessari et al., 2009). Intrahepatocellular fatty acids that are not oxidized will be 
esterified and incorporated in the lipoprotein and be secreted as VLDL. The 
secretion of VLDL can contribute to the decrease of TAG content in the hepatocyte. 
The progression of NAFLD also comes from the combined result of adipose tissue 
lipolysis, hepatic lipolysis of the circulating TAG, and the up take of free fatty acid 
by other tissues. 
The development of NAFLD is commonly accompanied with the changes of 
gene expression related to lipid metabolism, inflammatory response, and cell cycle 
control (Kirpich et al., 2011). The degree of nuclear factor-kappa B (NF-κB) 
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activation, mRNA expression of tumor necrosis factor alpha (TNF-α), 
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) increased in 
the rats with NAFLD induced by a HF diet, while the mRNA expression of 
glutathione peroxidase (GPx) and catalase (CAT) decreased significantly (Tipoe et 
al., 2009). An animal model of NAFLD induced by maternal HF diet demonstrated 
up-regulation of the lipogenesis, oxidative stress, and inflammatory pathways 
(Bruce et al., 2009). Yan Wang et al. reported an increase of apoptosis in an 
animal model of NAFLD induced by HF diet, associated with the c-Jun NH2-
terminal kinase (JNK) activation (Wang et al., 2008). Interestingly, the 
accumulation of p21Cip1, an inhibitor of cyclin dependent kinase and a marker of 
cellular senescence, was observed in NAFLD patients (Nakajima et al., 2010).  
To sum up, with the rapidly increasing prevalence of NAFLD, molecular and 
metabolic basis associated with the pathogesis of the disease is urgent to be 
identified. Future work to study the correlation of lipid metabolism, liver’s function 
of regeneration, and the hepatocellular inflammatory response may contribute to 
understand the mechanism behind the phenomenon.   
p16INK4a 
Various regulation of cell cycle has been identified in offspring from dams 
experienced undernutrition through gestation and lactation and in patients at 
different stages of chronic liver diseases. In order to establish the role of cell 
proliferation and senescence plays in those conditions, it is crucial to clarify the 
mechanism behind the complicated regulation of mammalian cell cycle. 
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Mitogen-dependent progression through the first gap (G1) phase and DNA 
synthesis (S) phase during the mammalian cell cycle is cooperated by several 
classes of cyclin dependent kinases (CDKs) whose activities are regulated by 
particular CDK inhibitors (CKIs). p16INK4a belongs to the family of inhibitors of CDK 
4 (INK4) which can only bind to CDK 4 or 6 and modifies the phosphorylation of 
retinoblastoma (Rb) protein who plays pivotal role in mediating the expression of 
downstream genes regulated by the complex formed by Rb and E2F protein 
(Dyson, 1998; Hunter and Pines, 1994; Mittnacht, 1998; Morgan, 1995; Serrano et 
al., 1993; Sherr, 1994; Sherr and Roberts, 1999). 
p16INK4a was firstly identified as a specific inhibitor of cyclin D/CDK4 in 1993 
by Serrano et al. (Serrano et al., 1993). They reported that the protein of p16INK4a 
can bind to CDK4 and inhibit the catalytic activity of CDK4/cyclin D in 
phosphorylating the downstream target proteins. In this report, they proposed 
p16INK4a to be both upstream and downstream of retinoblastoma protein (Rb) in a 
negative feedback loop. Further research on how this inhibitor of CDKs works to 
regulate cell cycle progression and how p16INK4a is regulated in the tightly control 
of cell proliferation or programmed death. 
In the absence of CKIs, mitogen-dependent cell progression through G1 
phase to S phase is positively regulated by the CDKs, whose activities rely mostly 
on the binding of cyclins. D-type cyclins are an important group of molecules that 
can bind to two major types of CDKs, CDK 4 and 6 (Hunter and Pines, 1994). D-
type cyclins have a very short turnover time, about 30 min, if they are not binding 
to the specific CDKs. The complex formed by cyclin D and CDKs is fundamental to 
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cell cycle regulation of Rb protein. Rb protein, whose phosphorylation is mainly 
catalyzed by CDK4/6/cyclin D, is not phophorylated through G1 phase. 
Hypophosphorylation of Rb protein arrests cells in G1 phase and phosphorylation 
can relieve this inhibition. 
With functional inhibitors of cyclin D-dependent kinases, p16INK4a, the 
enzyme activity of CDK4/6/cyclin D to phosphorylate the downstream protein will 
be inhibited. p16INK4a can bind to CDK4 in competition with cyclin D and inhibit the 
phosphorylation of Rb protein (Hannon and Beach, 1994). p16INK4a can inhibit 
CDK6/cyclin D assemble in the similar way. It was reviewed that p16INK4a 
accumulates progressively as cells age and may be induced by cellular 
senescence (Sherr and Roberts, 1999). 
Phosphorylation of Rb protein plays the central role in the p16INK4a 
regulated cell cycle pathway. Cyclin D activated CDK4/6 and cyclin E activated 
CDK 2 are responsible for the phosphorylation of Rb protein at different sites 
(Mittnacht, 1998). Different kind of CDIs charge for different CDK regulated 
phosphorylation of Rb protein and p16INK4a, as discussed above, can compete with 
cyclin D for the binding site of CDK4/6. The downstream target of Rb protein, E2F 
family, is an important regulator for several E2F-dependent transcriptions that are 
necessary for DNA synthesis. There are many members in the E2F family and 
they play vital roles in regulating the cell progression through G1 phase to S phase 
(Dyson, 1998) 
The abnormal expression of p16INK4a happens in various abnormal 
conditions. It has been reported that the gene of p16INK4a is deleted in many cases 
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of human cancers (Nobori et al., 1994). The gene of p16INK4a is located on the 
chromosome 9p21, which appears to be deleted in multiple types of cancers. In 
this aspect, the deletion of p16INK4a can be used in negatively diagnosing specific 
kinds of cancer. The level of p16INK4a plays critical role in balancing development 
and tumorigenesis (Elledge et al., 1996). p16INK4a transcription can be regulated 
through DNA methylation and aberrant methylation was observed in some 
diseases (Hinshelwood et al., 2009; Nishida et al., 2008). The loss of p16INK4a in 
mice showed increased rate of tumor development, while the overexpression of 
the gene arrests the cells in G1 phase.  
In conclusion, p16INK4a is an important inhibitor of CDK4/6 in competing with 
cyclin D for the binding site. The balanced expression and function of p16INK4a and 
CDKs are needed to maintain normal cell cycle progression.   
p21Cip1 
p21Cip1 belongs to the family of CDKs inhibitor protein and is a universal 
inhibitor of CDKs which include cyclin D-, E- and A-dependent kinases (Sherr and 
Roberts, 1999; Xiong et al., 1993). p21Cip1 binds to and inhibits a wide range of 
cyclin/CDKs complexes including cyclin D-dependent CDK4, cyclin A dependent 
CDK2 and cyclin E dependent CDK2 (Hunter and Pines, 1994). In some cases, 
the inhibition of forming the cyclin-CDK complex requires more than one p21Cip1 
molecules.  
The expression of p21Cip1 is regulated by the p53 tumor suppressor protein. 
mRNA expression of p21Cip1 is induced by DNA damage in a p53 positive cell line, 
while the expression of p21Cip1 remains the same under the same treatment in p53 
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negative cells (Xiong et al., 1993). On the promoter of p21Cip1 gene, there exists a 
binding site for p53 protein and the binding of p53 acts as a transcription factor for 
p21Cip1. In normal cells, p21Cip1 binds with CDK, cyclin and proliferating cell nuclear 
antigen to form a complex (Xiong et al., 1992). The inhibiting function of p21Cip1 on 
cell cycle progression after DNA damage relies on the induction of p53 and the 
resulting induction of p21Cip1. 
 The expression of p21Cip1 was abnormal in several conditions, including 
cancer, adipocyte differentiation and maternal protein restriction. Loss of p21Cip1 
expression was observed in 79% of colon cancer patients in a study of host-tumor 
interactions (Ogino et al., 2009). The interaction of p21Cip1 with cigarette smoking 
can affect the susceptibility to esophageal squamous cell carcinoma (Taghavi et 
al., 2010). In a p21Cip1 knockout model, vigorous apoptosis was observed as well 
as the activated p53 (Inoue et al., 2008). It has been reported that mRNA 
expression of p21Cip1 can be induced in the kidney and pancreatic islet cells of 
offspring from dams fed a LP diet (Luyckx et al., 2009; Tarry-Adkins et al., 2010; 
Tarry-Adkins et al., 2009). The increased expression of p21Cip1 and the associated 
hepatocellular senescence were observed in non-alcoholic fatty liver disease 
patients (Nakajima et al., 2010). 
In conclusion, mitogen-dependent cell cycle progression is under tightly 
control of the elaboration of cyclin, CDKs and the CDIs. The abnormal expression 
of p16INK4a and p21Cip1 was highly involved in several conditions including 
tumorigenesis and cellular senescence. The loss of expression of the inhibitors 
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can lead to the uncontrolled cell proliferation, while the increased expression may 
cause aging and senescence. 
Aging and Cellular Senescence 
Cellular senescence was primarily descript as the limited lifespan of cells in 
culture (Hayflick, 1965). According to the different causes of senescence, it can be 
divided into four classes: telomere-dependent senescence, DNA-damage-initiated 
senescence, oncogene-induced senescence and oxidation- and other-inducer-
induced senescence (Campisi and dda di, 2007). As discussed in previous 
paragraphs, p53-p21Cip1 and p16INK4a-Rb pathways are involved in cellular 
senescence. Generally speaking, DNA damage acts as a senescence signal and 
causes the activation of p53 to induce the inhibiting function of p21Cip1 in the cell 
cycle progression, while other senescence signals induce the expression of 
p16INK4a and cause the cell cycle arrest. 
Although both p53-p21Cip1 and p16INK4a-Rb pathways are involved in a 
senescence response, the roles played by these two CKIs are not equivalent. 
Cells undergo senescence induced solely by DNA damage and p53 activation can 
resume after the inactivation of p53 (Campisi and dda di, 2007). However, cells 
senesce completely because of p16INK4a-Rb activation cannot resume even after 
the inactivation of p16INK4a or Rb. The expression of p16INK4a was used as a 
biomarker of aging and senescence (Krishnamurthy et al., 2004). In this aspect, 
studying the p16INK4a-Rb senescence pathway is critical to understand how to 
maintain normal cell function. 
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The expression of p16INK4a is regulated by the transcriptional activator and 
inhibitor during cellular senescence. Ets family has many members of transcription 
factors, including Ets1, Ets2, PEA3, SAP1 and ELK1, which can be activated by 
Ras-Raf-MEK signaling through phosphorylation (Ohtani et al., 2001). In young 
diploid fibroblast cells, the expression of p16INK4a can be induced by the 
transcription activator Ets2 and be inhibited by the direct interaction with a helix-
loop-helix protein Id1. In senescence cells, it was found that the induction of 
p16INK4a is associated with the increase of the transcription activator Ets1 and the 
decrease of the inhibitor Id1. Another member of the Ets family of transcription 
factors, ESE3, was detected to be induced in cellular senescence, which agreed 
with the increased expression of p16INK4a (Fujikawa et al., 2007). Members of 
another family of transcription factors, Id proteins, have basic-helix-loop-helix 
structure and are repressed in senescent cells (Hara et al., 1994; Zebedee and 
Hara, 2001). The expression of p16INK4a can be regulated by other transcription 
factors through a manner of histone modification (Feng et al., 2009; Jung et al., 
2010). The network of interaction and collaboration of the transcription activators 
and inhibitors decides the expression of p16INK4a in senescence pathway. 
Cellular senescence can prevent the cells against cancer development. 
Senescent bile ductular cells increase in chronic liver diseases (Sasaki et al., 2010) 
and the proliferative activity of hepatocytes was decreased in human liver cirrhosis 
(Delhaye et al., 1999). Hepatocellular telomere shortening and senescence are 
considered as markers of liver cirrosis (Wiemann et al., 2002). However, the 
complex of senescent hepatocytes and ductular cells was lost before the 
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development of early hepatocarcinogenesis (Ikeda et al., 2009). Study on the 
replicate senescence in different stages of chronic liver diseases confirmed that 
the accumulation of senescent cells happens more often in the cirrhosis tissue 
surrounding the hepatocellular carcinoma (Paradis et al., 2001). A significant 
number of cells in premalignant tumors undergo oncogene-induced senescence 
and cells bypass the senescence are easier to develop tumor (Braig and Schmitt, 
2006; Ozturk et al., 2009). Experiencing cellular senescence provides protection 
for the premalignant cells against cancer development. 
The production of reactive oxygen species (ROS) accumulates as normal 
by-product of metabolism, which can increase to a significant amount that is 
harmful to cells and may lead to ROS-induced senescence when cells are 
experiencing stress. Substantial amount of evidence have shown that the 
induction of cellular senescence can be carried out through p53-p21Cip1 and 
p16INK4a-Rb pathways. Although the mechanism of how ROS contributes and 
induces senescence remains illusive, studies have demonstrated that ROS, 
oxidative stress and DNA damage collaborate to trigger senescence in a manner 
of DNA damage response (Ozturk et al., 2009). Oxidative stress can induce 
cellular senescence in cultured mouse biliary epithelial cells, suggesting the 
reason why progressive bile duct was lost in biliary cirrhosis (Sasaki et al., 2005). 
It was also reported that excessive ROS production can trigger the p53 activated 
senescence, which contributed to inflammatory disorders and associated aging 
(Kim et al., 2009). Mild hyperoxia can induce senescence via DNA-damage 
response (Chen et al., 1995; von et al., 1995). Decreased level of antioxidant 
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defense capacity and increased level of oxidative stress and ROS contribute to the 
induction of cellular senescence and body’s propensity to some chronic diseases 
(Burhans and Heintz, 2009). 
In conclusion, cellular senescence induced by excessive oxidative stress 
and ROS via p21Cip1, p16INK4a-Rb pathway is highly associated with the 
development of chronic diseases.  
Antioxidant Defense Genes 
Oxidative stress and the abnormal accumulation of ROS are well-known 
causes of cellular senescence. In cultured human retinal pigment epithelial (RPE) 
cells, H2O2 treatment triggered cellular senescence via p21Cip1-Rb pathway (Yu et 
al., 2009). p16INK4a and p21Cip1 accumulate in response to oxidative stress and 
induce cellular senescence via specific pathways, while antioxidant defense 
capacity of the body reduces the excessive ROS and protect the cells from 
senescence. 
Oxidative stress results from the accumulation of ROS (O2˙¯, H2O2, ˙OH), 
which are the normal by-product of metabolism but can excessively accumulate 
when organism losses the ability to eliminate them. Superoxide dismutase (Sod) is 
the enzyme converts O2˙¯ to H2O2 (Beyer et al., 1991) and glutathione peroxidase 
(Gpx) catalyzes the reaction converting H2O2 to H2O (Ursini et al., 1995). Both of 
them act very important role in antioxidant defense reactions. Three members 
exist in the family of Sod enzymes: Cu/ZnSOD (Sod1), MnSOD (Sod2) and 
ECSOD (Sod3) (Miao and St Clair, 2009). It was reported that loss of catalytic 
activity of Sod1 is associated with aging and aging-associated disease. In a Sod1 
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knock-out mice model, high rate of death from liver tumor was observed (Miao and 
St Clair, 2009). Alteration of Sod2 expression and activity has been reported to be 
related to the incidence of ROS-mediated cancer development. Loss or decreased 
activity of Gpx can lead to an oxidative-stress-mediated growth retardation and 
impairment of physical situation (Esposito et al., 2000; Shin et al., 2008). Studies 
on the interaction between maternal diet and antioxidant capacity in offspring show 
that selenium supplement in maternal diet is important to establish an effective 
antioxidant protection system in fetus (Pappas et al., 2008). 
There are three members in the paraoxonase (PON) enzyme family: PON1, 
PON2 and PON3. The sufficient expression and activity of these three enzymes 
can provide efficient reduction in low density lipoprotein (LDL) oxidation (Aviram 
and Rosenblat, 2004). More importantly, the decreased expression and activity of 
PON1 has been associated with chronic liver disease (Camps et al., 2009). It is 
important for the body to maintain a reasonable level of these enzymes in order to 
establish the effective antioxidant defense capacity. 
Cyclooxygenase 2 (Cox2) is the enzyme that catalyzes the conversion of 
arachidonic acid to some pro-inflammatory factors including prostanoids and 
thromboxanes (Funk, 2001). The expression of Cox2 presents extremely low in 
hepatocytes under normal condition but it will be induced if there exist lipid 
peroxides and oxidative stress. Expression of Cox2 is related to chronic liver 
disease and stress and Cox2-inhibitors suppress proliferation of hepatocellular 
carcinoma (HCC) cells (Hu, 2003). The induction of Cox2 is associated with pro-
inflammatory mediators and fatty liver disease (Hsieh et al., 2009; Kniss, 1999; Yu 
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et al., 2006). It was also reported that, by using Cox2-inhibitors, we can improve 
immune system function and decrease liver damage in septic rats (Li et al., 2009).  
In conclusion, increased oxidative stress and decreased antioxidant 
defense capacity can act as mediator for stress-induced senescence and chronic 
diseases.  Organism’s ability to eliminate the harmful substrates produced during 
metabolism is important to maintain a normal function of operating. 
Conclusion 
Appropriate maternal diet is an important predetermining requirement for 
the offspring to maintain a healthy condition in their life. Maternal malnutrition 
during pregnancy and lactation can program metabolic disorders in offspring, 
including obesity, type 2 diabetes, hypertension and fatty liver disease. Among the 
several organs that can be affected by inappropriate maternal nutrition, liver is an 
important one to be targeted because of the central role it plays in metabolism. 
Previous studies have shown the significant impact of maternal malnutrition on 
metabolic function of livers of offspring. It still remains elusive that how maternal 
HF diet during gestation and lactation can affect the livers of offspring. 
Tightly control of cell cycle is performed in normal proliferating mammalian 
cells through maintaining consistent amount of cyclin, CDKs and CKIs. It was 
reported that cancer and other disorders could be induced when there exists 
abnormal expression of CKIs. However, the impact of maternal HF diet on cell 
cycle control has been hardly addressed.  
The regulation of antioxidant defense genes and cell cycle control genes 
has been well defined while studying the mechanism of cellular senescence in 
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several in vivo and in vitro studies. Loss of antioxidant defense genes and 
increased oxidative stress can induce the accumulation of CKIs, which are 
responsible for the arrest of cell cycle. It needs to be further identified the impact of 
maternal HF diet on the expression of antioxidant defense genes and cell cycle 
control genes.  
To further our understanding of this topic, we planed to study the impact of 
maternal HF diet through gestation and lactation on the livers of offspring rats by 
evaluating the expression of antioxidant defense genes and cellular senescence 
genes. Oxidative stress and down stream factors in the pathway will be evaluated 
in the livers of offspring to illustrate the mechanism and regulation of any 
programmed difference between offspring from HF diet fed dams and those from 
C diet fed dams. 
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CHAPTER 3 
A MATERNAL HIGH FAT DIET REPRESSES THE EXPRESSION OF 
ANTIOXIDANT DEFENSE GENES AND INDUCES THE CELLULAR 
SENESCENCE PATHWAY IN THE LIVER OF MALE OFFSPRING RATS 
Abstract 
Maternal high fat (HF) diet feeding is associated with increased risk of 
developing metabolism-related diseases in adult offspring, including chronic liver 
disease. The present study tested the hypothesis that maternal high fat diet leads 
to a decreased antioxidant defense capacity and causes cellular senescence in 
liver of adult offspring rats, which might increase risk of developing chronic liver 
disease.  Timed-pregnant Sprague Dawley rats were fed a HF diet (45% of energy 
from fat) or a control (C) diet (16% of energy from fat) during gestation and 
lactation. The resulting offspring were fed a control diet after weaning, to generate 
two offspring groups: C/C and HF/C.  At 12 wk of age, male rats were killed and 
samples were collected for analysis.  Maternal HF diet significantly increased 
plasma triacylglycerol and hepatic thiobarbituric acid reactive substance 
concentrations and the size of hepatic lipid droplets in offspring rats. The 
expression of antioxidant defense genes, such as glutathione peroxidase-1 (Gpx1), 
Cu/Zn superoxide dismutase (Sod1), paraoxonase enzymes (Pon1, Pon2, and 
Pon3) were significantly lower in the liver of HF/C pups than in C/C pups. The 
expression of p16INK4a, a marker of cellular senescence, and cyclooxygenase-2 
(Cox2), a pro-inflammatory marker, was significantly higher in the HF/C offspring 
group than in the C/C offspring group.  Western blot analysis shows that cyclin D1 
and phosphorylated retinoblastoma (p-Rb) protein were significantly lower in HF/C 
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offspring than in C/C offspring.  The results provide the first evidence that maternal 
HF diet might alter antioxidant defense capacity and program the p16INK4a-
dependent cellular senescence in the liver of adult offspring. 
 
Keywords: Aging, Cancer, Oxidative stress, Non-alcoholic fatty liver disease, Lipid 
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Introduction 
Epidemiological studies have shown that maternal HF diet and the 
associated overweight affect insulin signaling (Shankar et al., 2010), brain appetite 
regulation (Rajia et al., 2010), immune function (Odaka et al., 2010), hepatic gene 
expression (Zhang et al., 2009), blood pressure (Elahi et al., 2009), plasma lipid 
(Elahi et al., 2009), and liver lipid metabolism (Chapman et al., 2000; 
Ghebremeskel et al., 1999; Higham et al., 1984; Innis, 1988; McCurdy et al., 2009).  
Long term HF diet consumption is associated with the increased plasma lipid level 
in offspring of mice (Elahi et al., 2009).  Additionally, maternal HF diet has been 
shown to be highly associated with chronic liver damage in offspring adults and 
non-alcoholic fatty liver disease (NAFLD) was reported in offspring of dams fed 
with HF diet (Bruce et al., 2009; McCurdy et al., 2009). 
p16INK4a (Inhibitor of cyclin dependent Kinase 4a) is a vital cell cycle control 
gene that binds to cyclin-dependent kinase4 (CDK4) and inhibits the formation of 
the active CDK4/cyclin D complex (Serrano et al., 1993).  p21Cip1 (cell cycle 
inhibitory protein 1) belongs to the Cip/Kip family, whose actions affect the 
activities of cyclin D, E and A dependent kinases (Sherr, 1994).  p16INK4a and 
p21Cip1 inhibit the active formation of cyclin/CDK, thereby decreasing the 
phosphorylation of Rb (Mittnacht, 1998).  Hypophosphorylation of Rb protein 
increases its binding to E2F, which correlates with a decrease of E2F-regulated 
transcription (Dyson, 1998).  E2F plays an important role as a transcription factor 
in either activating or suppressing crucial genes.  The phosphorylated Rb protein 
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will release E2F to activate the transcription of downstream DNA synthesis related 
genes which will increase the cells progression from G1 to S phase (Sherr, 1994). 
The p16INK4a-Rb senescence pathway is known to be induced by various 
stressful stimuli, including oxidative stress (Zhang, 2007). It has been reported in 
previous studies that decreased expression and activity of GPx1 in response to 
oxidative stress decreased antioxidant defense capacity of the organ (Esposito et 
al., 2000; Shin et al., 2008). Expression of COX2 is more related to chronic liver 
disease and stress and COX2-inhibitors suppress proliferation of hepatocellular 
carcinoma (HCC) cells (Hu, 2003) and to decrease liver damage (Li et al., 2009). 
The induction of COX2 is associated with pro-inflammatory mediators and fatty 
liver disease (Hsieh et al., 2009; Kniss, 1999; Yu et al., 2006). Another indicator of 
antioxidant defense response, SOD1, has been reported to convert harmful 
superoxide radicals to hydrogen peroxide and therefore neutralize the reactive 
oxygen species (de Haan et al., 1995).  The three members of the paraoxonase 
(PON) family of enzymes, PON1, PON2, and PON3 are efficient in reducing low 
density lipoprotein (LDL) oxidation (Aviram and Rosenblat, 2004).  The decreased 
expression and activity of PON1 has been associated with chronic liver disease 
(Camps et al., 2009).  
The relationship between diet and cellular senescence has been observed 
in other tissues.  Poor maternal nutrition can lead to low-birth-weight offspring that 
have accelerated cellular senescence after catch-up growth (Luyckx et al., 2009; 
Tarry-Adkins et al., 2009).  p16INK4a was induced in pancreatic islet cells of low-
birth-weight offspring rats (Tarry-Adkins et al., 2009).  Cellular senescence in 
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kidney was also triggered by the accelerated postnatal growth following maternal 
under-nutrition through the p16INK4a-pRb pathway (Luyckx et al., 2009).  
Additionally, during the development of emphysema in chronic obstructive 
pulmonary disease, p16INK4a was detected to link environment or nutritional stress 
and chronic disease (Karrasch et al., 2008). 
Liver is an important organ for studying the growth and cell cycle regulation 
because of its regenerative and metabolic capacity (Fausto et al., 2006).  Many 
studies focus on the role that cell cycle control genes play in hepatocellular 
carcinoma (HCC), and how nutrition during pregnancy affects chronic liver 
diseases development are not well understood.  The present study was designed 
to determine the effect of a maternal HF diet on antioxidant defense and p16INK4a-
pRb senescence pathway in the liver of offspring rats. We hypothesize that 
maternal HF diet during gestation and lactation has the potential to program the 
expression of cellular senescence and antioxidant defense genes by triggering 
hepatic oxidative stress in rat offspring. 
Experimental Methods 
Animals and treatment 
Timed-pregnant Sprague Dawley rats (Charles River Laboratories) were fed 
with either a HF or a C diet (Research Diets, Inc., New Brunswick, NJ, table 3-1) 
during gestation and lactation. Litter sizes were standardized to 10 pups. All 
offspring were weaned at 3 wk of age and male rats (n=10 of C/C pups and n=9 of 
HF/C pups from different litter) of the resulting offspring were fed a control diet 
after weaning, to generate two offspring groups: HF/C, C/C.  Rats were kept 
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individually in standard polycarbonate cages in a humidity- and temperature-
controlled room on a 12-h light-dark cycle and had free access to food and water. 
At 12 wk of age, male rats were killed by CO2 asphyxiation and the left lobe of the 
whole liver was collected, rapidly frozen in liquid nitrogen, and stored in -70°C for 
future use. We certify that all applicable institutional and governmental regulations 
regarding the ethical use of animals were followed during this research (University 
of Illinois Institutional Animal Care and Use Committee approval #09112). 
Biochemical assays in pups 
One hundred milligrams of frozen liver samples were ground using a mortar 
and pestle with liquid nitrogen and mixed with 0.3 mL saline (0.9% w/v NaCl). 
Homogenized samples were quickly frozen in liquid nitrogen and kept in -70°C 
until analysis. The samples were quickly thawed in 37°C and diluted 5 times to 1.5 
mL. Twenty microliters of the diluted samples were incubated with 20 µL 1% 
deoxycholate in 37°C for 5 min, and ten microliters of the samples were analyzed 
via the Thermo Infinity Triglycerides Liquid Stable Reagent (Thermo Fisher 
Scientific, Rockford, IL) following company protocol and using a commercially 
available standard reference kit (Verichem Laboratories, Providence, RI). Lowry 
assay was performed to determine the protein concentration, which was used to 
normalize the TAG concentration in liver. To determine plasma TAG levels, 
plasma samples were thawed on ice and analyzed accordingly following company 
protocol as for liver samples. NEFA concentration in liver was determined using a 
commercially kit (HR-2 Series, Wako Diagnostics, Richmond, VA). To determine 
lipid peroxidation and oxidative stress, a commercial thiobarbituric acid reactive 
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substances (TBARS) Assay Kit (Cayman Chemical Company, Ann Arbor, MI) was 
used to measure plasma and hepatic TBARS level accordingly following company 
protocol. 
Liver histology 
Frozen liver samples from offspring were embedded in O.C.T. compound 
(Gentaur, Kampenhout, Belgium) prior to sectioning. All sections were then 
stained with hematoxylin and eosin (H&E) or oil red O (ORO) kit (Newcomer 
Supply, Middleton, WI) and evaluated for steatosis and inflammation.  
RNA Isolation and cDNA synthesis 
To measure the relative mRNA level of target genes, qPCR was performed 
in a 96-well plate using a 7300 real time PCR System (Applied Biosystems) as 
previously described (Strakovsky et al., 2010). High efficiency of the machine and 
presence of a unique product were ensured by checking that the slope of the 
standard was in the range of -3.3 ± 0.3 and the R2 to be larger than 0.98. Kinetic 
analysis was conducted to detect the exponential phase of amplification in each 
well with 25 ng template cDNA. mRNA level of ribosomal protein L7a was utilized 
as the internal control.  In order to determine the gene transcription rate, primers 
were designed to amplify a region including both exon and intron of that gene. This 
procedure was adapted from a method described by Lipson and Baserga (Lipson 
and Baserga, 1989), except that pre-mRNA amounts were quantified by real time 
PCR.  The relative expression level of this region can indicate the pre-mRNA rate 
of the gene and further present the transcription rate. Primers used for qPCR were 
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designed using Vector NTI software (InforMax Inc., Frederick, MD) and all the 
primers used for real-time PCR are listed in Appendix A. 
Protein Isolation and Western blotting 
Fifty micrograms of frozen liver was ground in liquid nitrogen and put into 
500 µL protein sample buffer (0.125 mol/L Tris-HCl pH 6.8, 5% 2-mercaptoethanol, 
1% SDS, 20% glycerol, 0.4% bromophenol blue, protease inhibitor, phosphatase 
inhibitor). Protein samples were sonicated (Fisher Scientific model 100 Sonic 
Dismembrator) on ice with 25 pulses and standard long Lowry assay was 
performed to determine sample protein concentrations. Samples containing 45 µg 
of protein were resolved by 10% SDS-PAGE. Western analysis was performed as 
previously described (Strakovsky et al., 2010) using 1:1000 rabbit monoclonal 
antibody against Phospho-Rb (Ser807/811) (#9308, Cell Signaling Technology, 
Beverly, MA), 1:200 Cyclin D1 (sc-20044, Santa Cruz Biotechnology, Santa 
Cruz,CA) antibody to detect Cyclin D1 protein, 1:1000 COX2 (#4842, Cell 
Signaling Technology, Beverly, MA) antibody to detect COX2 protein, 1:10000 
Actin (sc-1616-R, Santa Cruz Biotechnology, Santa Cruz,CA) antibody to detect 
Actin protein, peroxidase-conjugated secondary antibody (Kirkegaard & Perry 
Laboratories, Gaithersburg, MD), and HRP-linked anti-biotin secondary antibody 
(#7075, Cell signaling). The secondary antibody was detected by applying Super 
Signal West Dura Extended Duration Substrate kit (Thermo Scientific, Rockford, IL) 
and western blot images were captured and analyzed by Chemi Doc system (Bio-
Rad) and Quantity One software (Bio-Rad). The result of p-Rb, Cyclin D1, and 
	   40 
COX2 protein expression level was normalized to the expression of actin, whose 
expression did not between groups.  
Flow cytometry 
Fifty milligrams of frozen liver was ground using a mortar and pestle in 
liquid nitrogen and was homogenized in phosphate buffered saline (PBS) with 5% 
fetal bovine serum (FBS). The homogenized samples were centrifuged twice at 
1.12 g for 2 min to collect the supernatant and the resulting cell suspension was 
washed twice with PBS with 5% FBS. The cells were counted using a 
hemocytometer and the concentration was adjusted to approximately 1 × 109 
cells/L. The cells were pelleted by centrifugation and were resuspended in PBS. 
The cell suspension was fixed and stored in -20°C until analysis. Propidium iodide 
(PI) was used to stain DNA and cell cycle analysis was performed using a BD 
Biosciences LSR II flow cytometer at the Flow Cytometry Facility (The W.M. Keck 
Center for Comparative and Functional Genomics, University of Illinois at Urbana-
Champaign). 
Statistical analysis 
Results are expressed as means ± SEM (animal numbers of specific 
experiments are described in the figure legends). Comparison of mRNA 
expression, protein level and physiological outcomes between HF/C and C/C 
groups were performed by Student’s t-test in SAS v. 9.1 (SAS Institute, Cary, NC). 
Body weight and food intake data were tested using repeated-measures 1-way 
ANOVA (SAS software). The presented SEM was calculated based on the SD and 
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the specific sample size if there exists unequal sample size. Differences between 
HF/C and C/C pups were considered to be statistically significant for P < 0.05. 
Results 
Physiological Observations 
Food intake and body weight 
The food intake of pups fed a maternal high fat diet (HF/C) did not differ 
from that of pups fed a maternal control diet (C/C). At 12 wk after weaning, there 
was no significant difference in body weight between the two offspring groups. 
(Figure 3-1)  
Lipid Profiles 
Plasma TAG levels of offspring in HF/C group were significantly higher 
(P<0.05) when compared to that of the C/C group. Hepatic TAG and NEFA 
concentration did not differ between HF/C and C/C pups. (Table 3-2) 
An index of lipid peroxidation and oxidative stress 
Plasma TBARS levels did not differ between HF/C and C/C offspring. 
Hepatic TBARS levels of pups in HF/C group were significantly higher (P<0.05) 
when compared to that of the C/C group. (Table 3-2) 
Liver histology 
Liver structure tested by H&E staining did not differ between HF/C and C/C 
pups (Figure 3-2A).  However, differences between lipid droplets were observed in 
Oil Red O staining in the livers of HF/C and C/C pups.  Although both HF/C and 
C/C pups had red staining (Figure 3-2B), the red droplets staining in HF/C pups 
were larger than those observed in C/C pups in all samples examined. 
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Cell cycle analysis on the frozen liver samples did not show difference 
between the two offspring groups (data not shown). 
Genes related to antioxidant defense capacity 
The levels of mRNA from antioxidant genes and markers of oxidation were 
affected in the liver of maternal HF pups.  Gpx1 mRNA expression was 
significantly lower in the HF/C group (P<0.05) when compared to C/C (Table 3-3).  
Sod1 mRNA expression was significantly lower (P<0.01) in HF/C group than in 
C/C group (Table 3-3). However, Sod2 mRNA expression did not differ between 
the two groups (Table 3-3).  The antioxidant enzymes, Pon1 (P<0.05), Pon2 
(P<0.05), and Pon3 (P<0.01) were significantly lower in HF/C pups than in C/C 
pups (Table 3-3).  
Cellular senescence pathway  
The mRNA level of Cox2 (Table 3-3) as well as the protein level of Cox2 
(Figure 3-3A) was increased 4 to 5-fold (P<0.01) in HF/C pups, indicating the 
inflammatory state of the liver is higher in HF/C pups.  The mRNA amount of 
p16INK4a was increased 4.7-fold (P<0.01) in the HF/C pups (Table 3-3). p21Cip1 
mRNA level did not differ between HF/C and C/C pups (Table 3-3).  p16INK4a 
transcription activity was significantly higher (P<0.01) in HF/C pups when 
compared to C/C pups (Figure 3-3B).  Protein level of ETS1 (Figure 3-3C), a 
transcription factor activating p16INK4a transcription, was also increased 3 fold in 
the liver of HF/C pups, whereas protein content of ID1 (Figure 3-3D), a 
transcription repressor was unchanged. 
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To demonstrate that p16INK4a-dependent cellular senescence pathway was 
affected, cyclin D1 and phosphorylated Rb protein levels were detected by 
western blotting.  Cyclin D1 protein was decreased 80% (P<0.01) in the HF/C 
pups compared with C/C pups (Figure 3-3E).  Phosphorylated-Rb protein was 
more than 60% lower (P<0.05) in HF/C rats compared with C/C pups, which 
consistent with the increase of p16INK4a mRNA (Figure 3-3F).  
Discussion 
We report in this study a novel finding that a maternal high fat diet during 
gestation and lactation leads to a decreased expression of genes responsible for 
the antioxidant defense capacity and an increase in markers of cellular 
senescence in the liver of offspring rats in spite of feeding a standard AIN 93 diet 
after weaning. 
The effects of maternal HF diet on offspring physiological outcomes include 
increased body fat, liver weight, liver lipid content, blood glucose and TAG in 
offspring rats (Guo and Jen, 1995; Koukkou et al., 1998). Long term HF diet was 
shown to raise plasma lipid content in the offspring (Elahi et al., 2009) and an 
increase in blood lipids potentially increased the risk of vascular diseases in 
adulthood (Barker, 1997), which is consistent with our results showing a 
significantly increase of plasma TAG in offspring fed a control diet whose mothers 
consumed a HF diet throughout gestation and lactation.  Although in the current 
study no significant difference in liver TAG concentration was observed between 
C/C and HF/C groups, we noted that the lipid droplets in HF/C pups were much 
larger than those observed in C/C pups.  A study with hepatic steatosis in obese 
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rats showed that a decrease in the size of the lipid droplets may parallel an 
improvement of the disease (Stringer et al., 2010).  Further research will be 
required to fully understand how lipid droplet size and locations affects lipid droplet 
metabolism and NAFLD development. 
Cellular senescence has been reported to be programmed by maternal 
diets. Maternal under-nutrition with postnatal catch-up growth accelerated cellular 
senescence in pancreatic islet cells (Tarry-Adkins et al., 2009) and kidney (Luyckx 
et al., 2009) in offspring rats.  In the present study, we did not observe any 
postnatal growth difference in our rat offspring.  However, both cyclin D1 and 
phosphorylated Rb protein were decreased significantly in HF/C offspring showing 
the activation of the p16INK4a cellular senescence pathway in liver of offspring from 
mothers fed a HF diet during gestation and lactation.  The ability of hepatocellular 
proliferation in response to chronic liver injury significantly decreases when 
cirrhosis occurs (Delhaye et al., 1999) and the expressions of cell cycle inhibitors 
like p16INK4a and p21Cip1 increase (Paradis et al., 2001).  Activation of the cellular 
senescence pathways prevents liver regeneration and the continuous liver 
damage further triggers the fibrotic scarring and cirrhosis (Wiemann et al., 2002).  
Our study suggests that early activation of the p16INK4a-Rb senescence 
programmed by maternal HF diet might accelerate chronic liver injury. 
Oxidative stress may lead to cellular senescence by causing DNA damage 
and alteration of telomere length (Chen et al., 1995; von et al., 1995). Oxidation 
results in the production of reactive oxygen species (ROS), which damage cell 
components and organ functions. Levels of ROS are controlled by the activity and 
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amount of antioxidant enzymes.  Normally, COX2 expression in hepatocytes is low, 
however, COX2 expression levels increase rapidly in the presence of oxidative 
stress (Yu et al., 2006).  In the present study, Cox2 mRNA and COX2 protein 
levels were significantly higher in HF/C pups, indicating increased oxidative stress 
in the liver of maternal HF offspring.  Low expression, low activity, or deficiency of 
SOD1 may lead to various diseases, including causes ApoB degradation and 
induces hepatic lipid accumulation (Uchiyama et al., 2006).  Low expression of 
GPx1 cause reduced body weight than normal animals and increased levels of 
lipid peroxides in the liver (Esposito et al., 2000).  Aberrant expression of COX2 is 
associated with liver injury (Li et al., 2009), insulin resistance, fatty liver (Hsieh et 
al., 2009), steatohepatitis (Yu et al., 2006), and HCC (Hu, 2003).  The expression 
and enzymetic activity of PONs have been associated with the cell ability to 
reduce oxidative stress (Camps et al., 2009).  A measurement of serum PON1 
activity can be used as an indicator of liver function and chronic liver impairment 
(Camps et al., 2009).  Our study demonstrated decreased mRNA expression of 
Sod1, Gpx1, Pon1, Pon2, and Pon3, increased mRNA and protein levels of COX2, 
and increased hepatic TBARS level in maternal HF offspring rats, suggesting that 
maternal HF increases hepatic inflammation and reduces antioxidant capacity, 
which potentially accelerates liver damage in these animals.  In the future, we will 
perform “second hit” study to see how liver respond to different types of diets if 
they had a maternal HF diet and how cellular senescence involve in fatty liver 
development. 
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In summary, we have demonstrated that maternal HF diet during gestation 
and lactation results in the activation of markers of cellular senescence associated 
with a increase in the size of the lipid droplets in livers of offspring of HF-fed dams.  
Our study also demonstrates that alteration of antioxidant defense capacity might 
hasten the occurrence of chronic liver injury.  Our results show the potential of 
maternal HF diet in triggering chronic liver diseases in the offspring.  Further 
studies are needed to establish the precise mechanism behind this phenomenon 
and to determine how these molecular disregulations affect later liver physiology 
and disease development. 
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Table 3-1.  Macro- and micronutrient composition of the diets in this study 
 Control High Fat 
  g/kg 
Protein  20 24 
Carbohydrate  64 41 
Fat  7 24 
Total energy, kJ/g  16.75 19.68 
Ingredient    
Casein  200 200 
L-Cystine  3 3 
Corn Starch  437.2 72.8 
Maltodextrin  100 100 
Sucrose  102 172.8 
Cellulose  50 50 
Soybean Oil  25 25 
Lard  47 177.5 
Mineral Mix1   10 10 
DiCalcium Phosphate 13 13 
Calcium Carbonate  5.5 5.5 
Potassium Citrate  16.5 16.5 
Vitamin Mix2   10 10 
Choline Bitartrate  2 2 
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Table 3-1. (cont.)    
  Control High Fat 
  g/kg 
Ingredient    
Yellow Dye #5  0.025 0 
Red Dye #40  0.025 0.05 
 
1Mineral mix (AIN-93): (Research Diets, Inc., New Brunswick) Product# S10026 
for rodent (Reeves et al., 1993). 
2Vitamin mix (AIN-93): (Research Diets, Inc., New Brunswick) Product# V10001 
for rodent (Reeves et al., 1993). 
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Table 3-2. Physiological outcomes of offspring of rat dams fed a HF diet or a C 
diet1 
 C/C HF/C 
Plasma TAG, mmol/L 0.275 ± 0.027 0.468 ± 0.061* 
Liver TAG, mmol/g2 7.86 ± 0.62 6.89 ± 0.76 
Liver NEFA, mmol/g2 0.106 ± 0.008 0.094 ± 0.005 
Plasma TBARS, µmol/L 14.9 ± 2.0 16.7 ± 3.0 
Liver TBARS, µmol/L 25.5 ± 0.9 29.9 ± 1.8* 
 
1All values are Mean ± SEM,  n = 9-10 rats. Asterisks indicated different from C/C: 
*P<0.05. 
2Values have been normalized to hepatic protein concentration. 
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Table 3-3. Expression of hepatic genes in offspring of rat dams fed a HF diet or a 
C diet1,2 
 C/C HF/C 
Gpx1 1.25 ± 0.07 0.89 ± 0.10* 
Sod1 1.47 ± 0.11 0.98 ± 0.12** 
Sod2 1.15 ± 0.08 1.13 ± 0.16 
Pon1 1.37 ± 0.09 0.97 ± 0.12* 
Pon2 1.16 ± 0.06 0.84 ± 0.11* 
Pon3 1.33 ± 0.07 0.90 ± 0.09** 
p16INK4a 0.13 ± 0.03 0.60 ± 0.15** 
Cox2 0.12 ± 0.02 0.63 ± 0.15** 
p21Cip1 1.24 ± 0.31 0.93 ± 0.28 
 
1All values are means ± SEM, n=9-10. *P<0.05, **P<0.01. 
2Expression of mRNA is the ratio to the expression of L7a. 
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Figure 3-1. Food intake and body weight graphs of HF/C and C/C rat offspring1 
 
 
1Food intake (A) and body weight (B) graphs of HF/C and C/C rat offspring. Values 
are Means ± SEM, n=9/10. 
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Figure 3-2. Histological assays1 
 
1Histological assays including H&E stain (A) and ORO stain (B) of livers of 
offspring of rat dams fed a HF diet or a C diet (20×). 
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Figure 3-3. Hepatic senescence pathway proteins and p16INK4a transcription rate1  
 
1Hepatic senescence pathway proteins including COX2 (A), Ets1 (C), Id1(D), 
Cyclin D1 (E) and phospho-Rb (F) and p16INK4a transcription rate (B) in livers of 
offspring of rat dams fed HF or C diet during gestation and lactation. Values are 
means ± SEM, n=9-10 or 4 (E,F). *Different from C/C, P<0.05. 
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APPENDIX A 
LIST OF PRIMERS FOR REAL-TIME QUANTITATIVE PCR 
Appendix A. List of primers for real-time quantitative PCR 
Gene name Sequence and locations Ensembl /NCBI ID 
Forward (p16+12F), 5′- TGC AGA TAG ACT 
AGC CAG GGC A -3′ 
p16INK4a 
(coding 
region) 
Reverse (p16+76R), 5′- CTT CCA GCA GTG 
CCC GCA -3′ 
ENSRNOT0000006
6011 
Forward (p16+5829F), 5′- CGG GTC ACC GAC 
AGG CAT AA -3′ 
 p16INK4a 
(transcription 
rate) 
Reverse (p16+5889R), 5′- TTG GAC CAC CCA 
TGC TCA CC -3′ 
 
Forward (p21+5100F), 5′- CCG AGA ACG GTG 
GAA CTT TGA C -3′ 
p21Cip1 
(coding 
region) 
Reverse (p21+5171R), 5′- GAA CAC GCT CCC 
AGA CGT AGT TG -3′ 
ENSRNOT0000000
0628 
Forward (GPX1+503F), 5'- AGT ACA TCA TTT 
GGT CCC CG -3' Gpx1 (coding 
region) Reverse (GPX1+575R), 5'- TCT GGA CCT ACC 
AGG AAC TTC T -3' 
NCBI Gene ID: 
24404 
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Appendix A. (cont.)  
Gene name Sequence and locations Ensembl /NCBI ID 
Forward (COX2+729F), 5'- GGT CAT CGG 
TGG AGA GGT GTA TCC -3' Cox2 (coding 
region) Reverse (COX2+801R), 5'- GAC GTG GGG 
AGG GTA GAT CAT GTC -3' 
ENSRNOT0000000
3567 
Forward (SOD1+239F), 5'- CAG CGG ATG 
AAG AGA GGC A -3' Sod1 (coding 
region) Reverse (SOD1+310R), 5'- ACA CAT TGG CCA 
CAC CGT C -3' 
ENSRNOT0000000
2885 
Forward (SOD2+738F), 5'- GTT TGC AAG AAG 
TGA AGC -3' Sod2 (coding 
region) Reverse (SOD2+801R), 5'- ACT ACA AAA CAC 
CCA CCA -3' 
ENSRNOT0000002
5794 
Forward (PON1+1149F), 5'- AGT GAG GCC 
ATC ATT TCA GCC -3' Pon1 (coding 
region) Reverse (PON1+1221R), 5'- ATT CGT TGG 
TGA GCG GAG ATC -3' 
ENSRNOT0000001
1823 
Forward (PON2+66F), 5'- TGG CTC TGA GTT 
TGC TAG GCA -3' Pon2 (coding 
region) Reverse (PON2+137R), 5'- TAA GTC GAC TTC 
TGA GCG CCA -3' 
ENSRNOT0000003
6460 
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Appendix A. (cont.)  
Gene name Sequence and locations Ensembl /NCBI ID 
Forward (PON3+243F), 5'- TTT GCA CCA GAC 
AAG CCA G -3' Pon3 (coding 
region) Reverse (PON3+316R), 5'- TCC AGT GCT TGT 
GCC TTT G -3' 
ENSRNOT0000001
2050 
Forward (L7a+64F), 5′- GAG GCC AAA AAG 
GTG GTC AAT CC -3′ 
L7a 
Reverse (L7a+127R),  5′- CCT GCC CAA TGC 
CGA AGT TCT -3′ 
ENSRNOT0000000
6754 
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Appendix A. (cont.) 
a. Validation for p16INK4a (coding region) primer 
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Appendix A. (cont.) 
b. Validation for p16INK4a (transcription rate) primer 
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Appendix A. (cont.) 
c. Validation for p21Cip1 (coding region) primer 
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Appendix A. (cont.) 
d. Validation for Gpx1 (coding region) primer 
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Appendix A. (cont.) 
e. Validation for Cox2 (coding region) primer 
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Appendix A. (cont.) 
f. Validation for Sod1 (coding region) primer 
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Appendix A. (cont.) 
g. Validation for Sod2 (coding region) primer 
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Appendix A. (cont.) 
h. Validation for Pon1 (coding region) primer 
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Appendix A. (cont.) 
i. Validation for Pon2 (coding region) primer 
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Appendix A. (cont.) 
j. Validation for Pon3 (coding region) primer 
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Appendix A. (cont.) 
k. Validation for L7a primer 
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APPENDIX B 
EXPERIMENTAL PROTOCOLS IN THIS STUDY 
a. Triacylglyceride (TAG) Measurement 
Reagant preparation 
1. Triglyceride Reagent 
Thermo Infinity (TR22421) 
2. A and B standards 
Matrix Plus Chemistry Reference Kit (9500 Verichem Lab Inc.) 
3. Phosphate Buffer Saline (PBS) 
4. 0.9% Saline 
5. 1% deoxycholate 
Sample preparation 
1. Weigh out approximately 100 mg of ground tissue into a 1.5 ml 
centrifuge tube 
2. Add 300 µl of 0.9% Saline 
3. Quick frozen in liquid nitrogen and store in -80°C until measurement 
4. Quick thaw the frozen samples in 37°C water bath and mix with 1.2 mL 
of 0.9% Saline 
5. Mix 20 µL of diluted sample with 20 µL of 1% deoxycholate. 
Standard preparation 
1. 245mg/dL –B Matrix Plus (no dilution) 
2. 200 mg/dL – 81.6 µL B Matrix Plus + 18.4 µL 1X PBS (Use for next 3 
dilutions) 
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3. 150 mg/dL – 37.5 µL of #2 dilution + 12.5 µL 1X PBS 
4. 100 mg/dL – 20 µL of #2 dilution + 20 µL 1X PBS 
5. 50 mg/dL – 8.8 µL of #2 dilution + 26.3 µL 1X PBS 
6. 10 mg/dL – A Matrix Plus (no dilution) 
7. Reference blank – 1X PBS 
Performing the assay 
1. Thaw samples 
2. Vortex each sample, then add 5 µL of each sample/standard into each 
well (triplicate) 
3. Add 200 µL of TAG reagent into all wells 
4. Incubate 5 min at 37°C 
5. Assay at wavelength=562 nm. 
b. Non-Esterified Fatty Acid (NEFA) Measurement 
Reagant preparation 
1. NEFA-HR reagent (Wako Diagnostics, Inc.) 
2. 0.9% Saline 
3. 1X PBS 
Performing the assay 
1. Pipet 5 µL of standard, control, or patient sample into well 
2. Add 200 µL Color Reagent A solution to each well  
3. Incubate plate in 37°C water bath for 5 min 
4. Use ELISA reader to measure absorbance at 550 nm of each sample 
5. Add 100 µL Color Reagent B Solution, then repeat steps 5 & 6. 
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6. Calculate results by plotting an linear model x y scatter plot of standards 
c. Thiobarbituric Acid Reactive Substances (TBARS) Assay 
Reagant preparation 
1. Thiobarbituric Acid (TBA) 
Commercial product from Sigma-Aldrich, item number: T5500 
2. Acetic Acid 
Dilute 20 mL glacial acetic acid with 80 mL ddH2O 
3. Sodium Hydroxide (10 mol/L) 
4. Malondialdehyde (MDA) Standard 
5. SDS solution (10%) 
6. To prepare color reagent 
Weigh 1060 mg TBA and dissolve with 100 mL diluted acetic acid. 
Adjust the pH of this liquid to 3.5 with 10 M NaOH (1.5 mL 
approximately). Make the total volume to 200 mL with ddH2O. 
Sample preparation 
1. Weigh out approximately 25 mg of ground tissue into a 1.5 ml centrifuge 
tube 
2. Add 250 µl of RIPA buffer with protease inhibitors of choice 
3. Sonicate for 25 times at power setting at 2 over ice 
4. Centrifuge the tube at 1,600 x g for 10 minutes at 4°C. Use the 
supernatant for analysis. Store supernatant on ice. If not assaying the same 
day, freeze at -80°C. The sample will be stable for one month 
5. Tissue homogenates do not need to be diluted before assaying. 
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Standard preparation 
Dilute 250 µl of the MDA standard with 750 µl of ddH2O to obtain a stock 
solution of 125 µM. Take eight 1.5 mL micro-centrifuge tubes and label them A-H. 
Add the amount of 125 µM MDA stock solution and water to each tube as 
described in the following table. 
Tube (number) MDA (µL) ddH2O (µL) MDA concentration (µM) 
A 0 1000 0 
B 5 995 0.625 
C 10 990 1.25 
D 20 980 2.5 
E 40 960 5 
F 80 920 10 
G 200 800 25 
H 400 600 50 
Performing the assay 
1. Label 15 mL plastic tubes with standard number or sample identification 
number. Add 100 µl of sample or standard to appropriately labeled 15 
mL tube 
2. Add 100 µl of SDS solution to tube and swirl to mix 
3. Add 4 ml of the color reagent forcefully down side of each tube 
4. Cap tubes and bound tubes to keep the tubes upright during boiling 
5. Add tubes to vigorously boiling water. Boil tubes for one hour 
6. After one hour, immediately remove the tubes and place in ice bath to 
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stop reaction. Incubate on ice for 10 minutes 
7. After 10 minutes, centrifuge the tubes for 10 minutes at 1,600 x g at 4°C 
8. Tubes are stable at room temperature for 30 minutes 
9. Load 150 µl (in duplicate) from each tube to either the clear plate 
10. Read the absorbance at 530-540 nm. 
Calculation 
1. Calculate the average absorbance of each standard and sample 
2. Subtract the absorbance value of the standard A (0 µM) from itself and 
all other values (both standards and samples). This is the corrected 
absorbance 
3. Plot the corrected absorbance values (from step 2 above) of each 
standard as a function of MDA concentration 
4. Calculate the values of MDA for each sample from the standard curve.  
€ 
MDA(µM) = (Correctedabsorbance) − (y − intercept)Slope
⎡ 
⎣ 
⎢ 
⎤ 
⎦ 
⎥  
d. H&E Staining 
Performing the staining 
1. 7 µm thickness of frozen liver was sectioned and attached to a polarized 
glass slide 
2. 70% of ethanol was used for 1 min to fix and remove the bedding media 
3. dH2O was use for 30 s until the slides look clear 
4. Hematoxylin was use to stain for 1 min 
5. Clarifier 2 was used to remove the extra hematoxylin for 30 s 
6. Slides were subjected to running water for 30 s 
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7. Eosin Y was used to stain for 20 s 
8. Three times of 100% ethanol were used for 30 s each 
9. Three times of Xylene were used for 30 s each 
10. Permount mounting media was used to mount the glass slide with the 
coverlips 
11. Scan slides under microscope (Nanozoomer, Hamamatsu). 
e. Oil-Red-O Staining 
Performing the staining 
1. 7 µm thickness of frozen liver was sectioned and attached to a polarized 
glass slide 
2. Wash section gently in water 
3. Rinse in 60% isopropanol 
4. Stain for 10 min in working Oil-Red-O 
5. Wash very well in 60% isopropanol 
6. Counterstain for 20 s in hematoxylin 
7. Wash slides in water to blue 
8. Mount from water with Permount mounting media 
9. Scan slides under microscope (Nanozoomer, Hamamatsu). 
f. mRNA Isolation 
1. Add 1 mL Tri-reagent to frozen ground sample 
2. Add 0.2 mL 1-Bromo-3-Choropropane (BCP) per 1 mL of Tri-reagent 
used 
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3. Vortex for 15 s or mix by inverting several times, incubate at RT for 15 
min 
4. Spin at 12000x g for 15 min in beer box 
5. Transfer aqueous phase to a fresh eppendorf tube 
6. Add 500 µL isopropanol per 1 mL of Tri-reagent used 
7. Vortex and incubate at room temperature for 5 min 
8. Spin at 12000x g for 10 min in beer box and remove the supernatant 
9. Add 1 mL 75% ethanol per 1 mL of Tri-reagent used 
10. Vortex and spin at 7500x g for 5 min in beer box 
11. Discard ethanol and air dry RNA pellet for 5-10 min at room temperature 
12. Add RNase-free H2O to resolve RNA and make sure the concentration 
of RNA is between 500-1000 µg/µL 
13. Take 48.5 µL of the resolved RNA and incubate with 0.5 µL DNase I + 
1.5 µL 0.1 mol/L MgCl2 at 95°C for 20 min 
14. Measure the concentration of resulting RNA and use RNase free water 
to adjust the concentration to 200 µg/µL. 
g. Reverse Transcription (RT) 
Prepare the RT master mix use High Capacity cDNA kit from ABI 
1. Allow kit components to thaw on ice; mix and spin down every tube 
before use 
2. Calculate the volume of components needed to prepare the 2x RT 
reaction using the RNA calculator.  Mix enough for all the samples to be 
done. 
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Component 
Volume 
(µL)/rxn 
Total needed 
(  rxns) 
10X  Reverse Transcription Buffer 2  
25X dNTPs (100mM) 0.8  
10X random primers 2  
MultiScribe Reverse Transcriptase, 50U/µL 1  
Nuclease-free H2O 4.2  
Total per reaction 10  
Prepare the reaction 
1. Pipette 10 µL of 2x RT master mix into each well 
2. Pipette 10 µL RT template into each well.  Pipette up and down two 
times to mix 
3. Close the caps 
4. Place the strip or plate on ice until you are ready to load the thermal 
cycler. 
Thermal Cycler Program 
 Step 1 Step 2 Step 3 Step 4 
Temperature 25°C 37°C 85°C 4°C 
Time 10 min 120 min 5 sec hold 
Storage of the reaction 
1. Do not store the reaction in the reaction strip or plate 
2. Spin down the strips or plates in the rotor for microplate 
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3. Transfer the RT product to nuclease-free microfuge tubes and dilute 
with nuclease free TE (pH 8.0).  For cDNA standards, dilute the RT 
product to 100 µL final volume.  For unknown samples, dilute to 400 µL 
final volume 
4. Store the reaction at 4°C. 
h. Quantitative Real-Time PCR 
Prepare master mix for real time PCR 
 Total needed 
Component 
Volume 
µL/ reaction  
2X SYBR Green PCR Master Mix 10.0  
Sense primer (5 µM) 1.0  
Antisense primer (5 µM) 1.0  
H2O 3  
Total per reaction 15  
Template preparation 
1. The final concentration for a given unknown sample after the RT is 5 
ng/µL, that is 25 ng per well for PCR 
2. For Standard curve: do several regular RT and combine together for a 
good stock to start with.  Combine and dilute to 40 ng/µL cDNA, that’s 
20 µL RT product to 50 µL final volume.  Typically start a standard curve 
with 100ng, 50ng, 25ng, 12.5ng, 6.25ng per well.   
Assemble PCR reaction for each well  
1. Use plates or strips designed for real time PCR machine.   
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2. Pipette 15 µL of prepared master mix into each well first 
3. Pipette 5 µL template to each well.  Mix well by pipetting up and down 2-
3 times. 
 
i. Cell Cycle Analysis 
1. Weigh out 50 mg ground frozen sample and homogenize with 1 mL PBS 
containing 5% Fetal Bovine Serum (FBS) until clear 
2. Spin at 100 rpm for 2 min and transfer the supernatant to a fresh 15 mL 
tube 
3. Repeat step 3, add 3 mL PBS containing 5% FBS to resulting liquid 
4. Wash with PBS containing 5% FBS twice, spin at 800 rpm for 5 min 
5. Count cells under microscope and adjust concentration to 1×106 
cells/mL using PBS with 5% FBS 
6. Take out 0.5-1.0×106 cells and collect by centrifuge at 800 rpm for 5 min 
7. Use 0.5 mL cold PBS to resuspend the cell pellet and add 0.5 mL cold 
100% ethanol slowly to fix 
8. Store at -20°C until analysis 
9. Before analysis, pellet cells by spinning at 1000 rpm for 5 min in beer 
box and discard the liquid, let the ethanol evaporate 
 Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 
Temperature 95°C 95°C 60°C 95°C 55°C 95°C 
Time 10 min 15 s 1 min 15 s 1 min 15 s 
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10. Add 0.5 mL PBS, 5 µL 100 µg/mL RNase A and 10 µL 250 µg/mL 250 
µg/mL Propidium Iodide 
11. Mix well and incubate at room temperature in dark for ≥ 20 min 
12. Analyze by flow cytometry. 
 
